查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1528051

核医学影像设备的全球市场

Nuclear Medicine Imaging Equipment
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 267 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2030年全球核医影像设备市场预计将达到45亿美元

2023年全球核医影像设备市场估计为31亿美元，预计2030年将达45亿美元，2023-2030年分析期间复合年增长率为5.7%。单光子发射电脑断层扫描 (SPECT) 系统是本报告分析的细分市场之一，预计复合年增长率为 6.1%，到分析期结束时将达到 22 亿美元。在分析期间，混合正子扫描 (PET) 系统领域的复合年增长率预计为 5.8%。

美国市场预计将达8.101亿美元，中国预计复合年增长率为8.7%

2023年美国核医影像设备市场预估为8.101亿美元。中国作为全球第二大经济体，预计2030年市场规模将达到10亿美元，2023年至2030年的分析期间复合年增长率为8.7%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 3.4% 和 4.6%。在欧洲，德国的复合年增长率预计为 4.2%。

全球核子医学影像设备市场—主要趋势与驱动因素总结

为什么核医学影像设备在现代医疗保健中至关重要？

核子医学影像设备透过提供对于准确诊断和治疗计划至关重要的内部结构和功能的详细影像，在现代医疗保健中发挥重要作用。这些设备，例如正子断层扫描 (PET) 扫描仪和单光子发射断层扫描 (SPECT) 系统，利用少量放射性物质来视觉化生理过程。这可以及早发现癌症、心血管疾病和神经系统疾病等疾病。与其他诊断影像方式不同，核医技术能够评估组织和器官的解剖学和功能方面，为制定有效的治疗策略提供必要的全面见解。核医学影像能够在分子层面上检测异常，通常有助于早期诊断。

技术进步如何形塑核子医学影像设备？

技术进步显着提高了核医学影像设备的能力和应用。检测器技术的创新，例如固体检测器的开发，提高了影像解析度和灵敏度，从而实现更精确和准确的成像。 PET/CT 和 SPECT/CT 等混合成像技术的整合将核医学的功能性影像能力与电脑断层扫描 (CT) 的解剖细节融为一体，提供了更全面的诊断工具。此外，影像处理软体和人工智慧 (AI) 的进步正在简化影像分析和解释，使其更快、更准确。这些技术进步不仅提高了核医影像的诊断准确性，还扩大了其在个人化医疗中的应用，即根据对患者独特疾病概况的详细了解来客製化治疗方案。

核子医学扫描术诊断有哪些新趋势和创新？

核医学影像市场正在见证一些正在改变其面貌的新趋势和创新。一个显着的趋势是放射性药物的使用增加，这是一种含有放射性同位素的药物，用于诊断和治疗。新型放射性药物的开发正在扩大核医可诊断和治疗的疾病范围，包括各类癌症和慢性病。另一个主要趋势是越来越多地采用数位 PET 和 SPECT 系统，与传统类比系统相比，这些系统可提供更高的影像品质并缩短扫描时间。分子成像的兴起也值得注意。分子成像使生物体内的细胞和分子过程可视化，为更精确和有针对性的治疗铺平了道路。此外，核医学影像与磁振造影（MRI）等其他诊断方式的整合正在创建多模态影像平台，可以更全面地了解患者的健康状况。

推动核医影像设备市场成长的因素有哪些？

核医学影像设备市场的成长受到多种因素的推动。首先，癌症和心血管疾病等慢性病的盛行率不断上升，推动了对能够进行早期准确检测的先进诊断工具的需求。技术进步，包括混合成像系统的开发以及人工智慧在影像分析中的集成，正在使核医学成像更加高效和方便。放射性药物越来越多地用于诊断和治疗应用也是扩大核子医学范围的重要驱动力。此外，对个人化医疗的日益重视正在推动核医学成像技术的采用，该技术可以提供对疾病的分子和功能方面的详细了解。监管支援和有利的报销政策使医疗保健提供者和患者更容易获得这些先进的成像技术，从而推动市场成长。最后，对医疗基础设施的投资增加以及对核子医学扫描术诊断益处的认识不断提高，进一步推动了市场扩张，这些先进的诊断工具在现代医疗保健中继续发挥重要作用。

受访企业范例（共29家）

  • Digirad Corporation
  • GE Healthcare
  • Mediso Medical Imaging Systems
  • Philips Healthcare
  • Positron Corporation
  • Siemens Healthineers

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 比赛

简介目录
Product Code: MCP-1228

Global Nuclear Medicine Imaging Equipment Market to Reach US$4.5 Billion by 2030

The global market for Nuclear Medicine Imaging Equipment estimated at US$3.1 Billion in the year 2023, is expected to reach US$4.5 Billion by 2030, growing at a CAGR of 5.7% over the analysis period 2023-2030. Single-Photon Emission Computed Tomography (SPECT) Systems, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$2.2 Billion by the end of the analysis period. Growth in the Hybrid Positron Emission Tomography (PET) Systems segment is estimated at 5.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$810.1 Million While China is Forecast to Grow at 8.7% CAGR

The Nuclear Medicine Imaging Equipment market in the U.S. is estimated at US$810.1 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$1.0 Billion by the year 2030 trailing a CAGR of 8.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.4% and 4.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.2% CAGR.

Global Nuclear Medicine Imaging Equipment Market - Key Trends and Drivers Summarized

Why Is Nuclear Medicine Imaging Equipment Essential in Modern Healthcare?

Nuclear medicine imaging equipment plays a crucial role in contemporary healthcare by providing detailed images of the body’s internal structures and functions, which are vital for accurate diagnosis and treatment planning. These devices, such as positron emission tomography (PET) scanners and single-photon emission computed tomography (SPECT) systems, utilize small amounts of radioactive materials to visualize physiological processes. This allows for the early detection of diseases, including cancer, cardiovascular diseases, and neurological disorders. Unlike other imaging modalities, nuclear medicine techniques can assess both the anatomical and functional aspects of tissues and organs, providing comprehensive insights that are essential for formulating effective treatment strategies. The ability of nuclear medicine imaging to detect abnormalities at the molecular level often leads to earlier diagnosis, which is critical for improving patient outcomes and managing diseases more effectively.

How Are Technological Advancements Shaping Nuclear Medicine Imaging Equipment?

Technological advancements are significantly enhancing the capabilities and applications of nuclear medicine imaging equipment. Innovations in detector technology, such as the development of solid-state detectors, have improved image resolution and sensitivity, enabling more precise and accurate imaging. The integration of hybrid imaging technologies, such as PET/CT and SPECT/CT, combines the functional imaging capabilities of nuclear medicine with the anatomical detail of computed tomography (CT), offering a more comprehensive diagnostic tool. Furthermore, advances in image processing software and artificial intelligence (AI) are streamlining image analysis and interpretation, making it faster and more accurate. These technological improvements not only enhance the diagnostic accuracy of nuclear medicine imaging but also expand its use in personalized medicine, where treatments are tailored based on detailed insights into the patient’s specific disease profile.

What Are the Emerging Trends and Innovations in Nuclear Medicine Imaging?

The nuclear medicine imaging market is witnessing several emerging trends and innovations that are poised to transform its landscape. One prominent trend is the increasing use of radiopharmaceuticals, which are drugs that contain radioactive isotopes used in both diagnosis and treatment. The development of new radiopharmaceuticals is expanding the range of conditions that can be diagnosed and treated with nuclear medicine, including various types of cancer and chronic diseases. Another significant trend is the growing adoption of digital PET and SPECT systems, which offer enhanced image quality and reduced scan times compared to traditional analog systems. The rise of molecular imaging is also noteworthy, as it allows for the visualization of cellular and molecular processes in living organisms, paving the way for more precise and targeted therapies. Additionally, the integration of nuclear medicine imaging with other diagnostic modalities, such as magnetic resonance imaging (MRI), is creating multi-modal imaging platforms that provide a more holistic view of the patient’s health.

What Factors Are Driving the Growth in the Nuclear Medicine Imaging Equipment Market?

The growth in the nuclear medicine imaging equipment market is driven by several factors. Firstly, the increasing prevalence of chronic diseases, such as cancer and cardiovascular disorders, is fueling the demand for advanced diagnostic tools that can provide early and accurate detection. Technological advancements, including the development of hybrid imaging systems and the integration of AI in image analysis, are making nuclear medicine imaging more efficient and accessible. The expanding use of radiopharmaceuticals in both diagnostic and therapeutic applications is also a significant driver, as it broadens the scope of nuclear medicine. Additionally, the rising emphasis on personalized medicine is driving the adoption of nuclear imaging techniques that offer detailed insights into the molecular and functional aspects of diseases. Regulatory support and favorable reimbursement policies are facilitating market growth by making these advanced imaging technologies more accessible to healthcare providers and patients. Lastly, increasing investments in healthcare infrastructure and the growing awareness about the benefits of nuclear medicine imaging are further propelling the market’s expansion, ensuring that these advanced diagnostic tools continue to play a vital role in modern healthcare.

Select Competitors (Total 29 Featured) -

  • Digirad Corporation
  • GE Healthcare
  • Mediso Medical Imaging Systems
  • Philips Healthcare
  • Positron Corporation
  • Siemens Healthineers

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Nuclear Medicine Imaging Equipment - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Prevalence of Chronic Diseases Spurs Growth in Nuclear Medicine Imaging Equipment Market
    • Technological Advancements in Detector Technology Propel Market Expansion
    • Development of New Radiopharmaceuticals Expands Addressable Market Opportunity
    • Hybrid Imaging Technologies Strengthens Business Case for Integrated Diagnostic Solutions
    • Adoption of Digital PET and SPECT Systems Drives Market Growth
    • Growing Focus on Molecular Imaging Generates Demand for Advanced Nuclear Medicine Equipment
    • Integration with AI and Image Processing Software Enhances Diagnostic Accuracy and Drives Adoption
    • Increasing Awareness and Acceptance of Nuclear Medicine Imaging Drives Adoption
    • Emerging Applications in Oncology and Cardiology Sustain Growth in Market Demand
    • Advances in Non-Invasive Imaging Technologies Propel Growth in Diagnostic Capabilities
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Nuclear Medicine Imaging Equipment Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Nuclear Medicine Imaging Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Nuclear Medicine Imaging Equipment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Single-Photon Emission Computed Tomography (SPECT) Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Single-Photon Emission Computed Tomography (SPECT) Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Single-Photon Emission Computed Tomography (SPECT) Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Hybrid Positron Emission Tomography (PET) Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Hybrid Positron Emission Tomography (PET) Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Hybrid Positron Emission Tomography (PET) Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Planar Scintigraphy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Planar Scintigraphy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Planar Scintigraphy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Nuclear Medicine Imaging Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 14: USA Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 15: USA Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: USA 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 17: Canada Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 18: Canada Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: Canada 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • JAPAN
    • Nuclear Medicine Imaging Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 20: Japan Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: Japan Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: Japan 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • CHINA
    • Nuclear Medicine Imaging Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 23: China Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: China Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: China 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • EUROPE
    • Nuclear Medicine Imaging Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Nuclear Medicine Imaging Equipment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: Europe 16-Year Perspective for Nuclear Medicine Imaging Equipment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Europe 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • FRANCE
    • Nuclear Medicine Imaging Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 32: France Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: France Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: France 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • GERMANY
    • Nuclear Medicine Imaging Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 35: Germany Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Germany Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Germany 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 38: Italy Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Italy Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Italy 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Nuclear Medicine Imaging Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 41: UK Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: UK Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: UK 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 44: Spain Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Spain Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Spain 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 47: Russia Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Russia Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Russia 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Rest of Europe Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Rest of Europe 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Nuclear Medicine Imaging Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Nuclear Medicine Imaging Equipment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Asia-Pacific 16-Year Perspective for Nuclear Medicine Imaging Equipment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Asia-Pacific 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Nuclear Medicine Imaging Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 59: Australia Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Australia Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Australia 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • INDIA
    • Nuclear Medicine Imaging Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 62: India Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: India Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: India 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 65: South Korea Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: South Korea Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: South Korea 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 68: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Rest of Asia-Pacific Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Rest of Asia-Pacific 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Nuclear Medicine Imaging Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 71: Latin America Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 72: Latin America Historic Review for Nuclear Medicine Imaging Equipment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Latin America 16-Year Perspective for Nuclear Medicine Imaging Equipment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 74: Latin America Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Latin America Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Latin America 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 77: Argentina Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Argentina Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Argentina 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 80: Brazil Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Brazil Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Brazil 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 83: Mexico Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Mexico Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Mexico 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 86: Rest of Latin America Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Rest of Latin America Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Rest of Latin America 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Nuclear Medicine Imaging Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 89: Middle East Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 90: Middle East Historic Review for Nuclear Medicine Imaging Equipment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Middle East 16-Year Perspective for Nuclear Medicine Imaging Equipment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 92: Middle East Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Middle East Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Middle East 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 95: Iran Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Iran Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Iran 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 98: Israel Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Israel Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Israel 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 101: Saudi Arabia Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Saudi Arabia Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Saudi Arabia 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 104: UAE Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: UAE Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: UAE 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 107: Rest of Middle East Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Rest of Middle East Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Rest of Middle East 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • AFRICA
    • Nuclear Medicine Imaging Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 110: Africa Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Africa Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Africa 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030

IV. COMPETITION